Genom Biotech Private Limited, a active private limited company, was established on 31 January 2000 in Sinnar, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH2000PTC123931. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹8.00 Cr and a paid-up capital of ₹7.85 Cr.
It upholds a compliant status. Employing 5 professional, Its leadership includes Raunit Rathor (Director), Managobinda Dalai (Director), Singh Binod Kumar Sheila (Director). Past directors included Nilanchal Nahak, Shalini Srivastava, Satyajeet Kumar. It holds ₹34.38 Cr open charges and ₹7.70 Cr settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at D: 121,122, 123,M.I.D.C., Malegaon Sinnar, Nasik, Sinnar, Maharashtra, 422103.
U24239MH2000PTC123931
123931
31 January 2000
₹8.00 Cr
₹7.85 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Genom Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raunit Rathor | Director | 27 Oct 2018 | Current |
| Managobinda Dalai | Director | 10 May 2021 | Current |
| Singh Binod Kumar Sheila | Director | 01 Jun 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 23 Jun 2017 | Past |
| Pramod Abcsdd | Additional Director | 03 Nov 2021 | Past |
| Pramod Abcsdd | Director | 07 Jan 2011 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genom Biotech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 27.32% increase. The company also saw a substantial fall in profitability, with a 12.07% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Genom Biotech had a promoter holding of 70.00% and a public holding of 30.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹343,848,000.00
₹77,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2005 | Vijaya Bank | ₹3.00 Cr | Open |
| 09 Mar 2005 | Vijaya Bank | ₹2.50 M | Open |
| 01 Jan 2005 | B.K.C. | ₹2.50 M | Open |
| 31 May 2004 | Hdfc Bank Ltd. | ₹3.50 Cr | Open |
| 03 Apr 2004 | Bank Of India | ₹13.51 Cr | Open |
Explore comprehensive loan charge details -
Genom Biotech has a workforce of 5 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Genom Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genom Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Managobinda Dalai was appointed as a Director was appointed as a Director on 10 May 2021 & has been associated with this company since 4 years 6 months . was recorded as a recent event.
The activity Genom Biotech Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.
The activity Genom Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was completed.
Singh Binod Kumar Sheila was appointed as a Director was appointed as a Director on 01 Jun 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.
The activity Raunit Rathor was appointed as a Director was appointed as a Director on 27 Oct 2018 & has been associated with this company since 7 years 1 month . was completed.
Progress on A charge registered on 15 Oct 2008 via Charge ID 10128438 with The Saraswat Co-Operative Bank Ltd. was fully satisfied on 05 Feb 2018. was documented.
The CIN of Genom Biotech Private Limited is U24239MH2000PTC123931.
Genom Biotech Private Limited is headquartered at D: 121,122, 123,M.I.D.C., Malegaon Sinnar, Nasik, Sinnar, Maharashtra, 422103.
Genom Biotech Private Limited was incorporated on 31 January 2000.
The current directors of Genom Biotech Private Limited are
The primary industry of Genom Biotech Private Limited is Manufacturing.
Genom Biotech Private Limited is unlisted.
The authorized capital of Genom Biotech Private Limited is ₹8.00 Cr, and the paid-up capital is ₹7.85 Cr.
The compliance status of Genom Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX